Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis

被引：115
|
作者：
Weide, B. [1 ]
Elsaesser, M. [1 ]
Buettner, P. [2 ]
Pflugfelder, A. [1 ]
Leiter, U. [1 ]
Eigentler, T. K. [1 ]
Bauer, J. [1 ]
Witte, M. [3 ]
Meier, F. [1 ]
Garbe, C. [1 ,2 ]
机构：
[1] Univ Med Ctr, Ctr Dermatooncol, Dept Dermatol, D-72076 Tubingen, Germany
[2] James Cook Univ, Skin Canc Res Grp, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia
[3] Univ Med Ctr, Dept Gen & Transplant Surg, D-72076 Tubingen, Germany
来源：
BRITISH JOURNAL OF CANCER | 2012年 / 107卷 / 03期
关键词：
lactate dehydrogenase; melanoma; metastasectomy; prognosis; S100; STAGE-IV-MELANOMA; AMERICAN JOINT COMMITTEE; ONCOLOGY-GROUP TRIALS; MALIGNANT-MELANOMA; PROGNOSTIC-FACTORS; SURGICAL-TREATMENT; GERMAN GUIDELINES; SURVIVAL; PROTEIN; S100-BETA;
D O I：
10.1038/bjc.2012.306
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
BACKGROUND: Established prognostic factors are of limited value to predict long-term survival and benefit from metastasectomy in advanced melanoma. This study aimed to identify prognostic factors in patients with distant metastasis. METHODS: We analysed overall survival of 855 institutional melanoma patients with distant metastasis by bivariate Kaplan-Meier survival probabilities and multivariate Cox hazard regression analysis. RESULTS: Serum lactate dehydrogenases (LDH), S100B, the interval between initial diagnosis and occurrence of distant metastasis, the site of distant metastases, and the number of involved distant sites were significant independent prognostic factors in both bivariate and multivariate analyses. Visceral metastases other than lung (hazard ratio (HR) 1.8), elevated S100B (HR 1.7) and elevated LDH (HR 1.6) had the highest negative impact on survival. Complete metastasectomy was likewise an independent prognostic factor in multivariate analysis. This treatment was associated with favourable survival for patients with normal LDH and S100B values (5-year survival, 37.2%). CONCLUSION: The serum markers LDH and S100B were both found to be prognostic factors in melanoma patients with distant metastasis. Furthermore, complete metastasectomy had an independent favourable prognostic impact in particular for the patient subgroup with normal LDH and S100B values. British Journal of Cancer (2012) 107, 422-428. doi: 10.1038/bjc.2012.306 www.bjcancer.com Published online 10 July 2012 (C) 2012 Cancer Research UK
引用
收藏
页码：422 / 428
页数：7
相关论文
共 50 条
  • [21] The Relationship of Serum S100B Levels with Infarction Size and Clinical Outcome in Acute Ischemic Stroke Patients
    Selcuk, Ozlem
    Yayla, Vildan
    Cabalar, Murat
    Guzel, Vildan
    Uysal, Samiye
    Gedikbasi, Asuman
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2014, 51 (04): : 395 - 400
  • [22] Serum S100B is suitable for prediction and monitoring of response to chemoimmunotherapy in metastatic malignant melanoma
    Hamberg, AP
    Korse, CM
    Bonfrer, JMG
    de Gast, GC
    MELANOMA RESEARCH, 2003, 13 (01) : 45 - 49
  • [23] Biomarker value and pitfalls of serum S100B in the follow-up of high-risk melanoma patients
    Gebhardt, Christoffer
    Lichtenberger, Ramtin
    Utikal, Jochen
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 (02): : 158 - 164
  • [24] Prognostic significance of serum S100B detection compared with routine blood parameters in advanced metastatic melanoma patients
    Hauschild, A
    Michaelsen, J
    Brenner, W
    Gläser, R
    Henze, E
    Christophers, E
    MELANOMA RESEARCH, 1999, 9 (02) : 155 - 161
  • [25] S100B in bone marrow aspirates in healthy individuals and malignant melanoma patients
    Faye, Ragnar S.
    Paus, Elisabeth
    Maelandsmo, Gunhild M.
    Berner, Aasmund
    Hoifodt, Hanne K.
    Fodstad, Oystein
    Aamdal, Steinar
    MELANOMA RESEARCH, 2008, 18 (02) : 134 - 140
  • [26] Neurofilament light chain and S100B serum levels are associated with disease severity and outcome in patients with aneurysmal subarachnoid hemorrhage
    Zhou, Zhangming
    Zeng, Junyi
    Yu, Shui
    Zhao, Ying
    Yang, Xiaoyi
    Zhou, Yiren
    Liang, Qingle
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [27] Can early serum levels of S100B protein predict the prognosis of patients with out-of-hospital cardiac arrest?
    Song, Kyoung Jun
    Shin, Sang Do
    Ong, Marcus Eng Hock
    Jeong, Joong Sik
    RESUSCITATION, 2010, 81 (03) : 337 - 342
  • [28] S100B protein detection in serum is a significant prognostic factor in metastatic melanoma
    Hauschild, A
    Engel, G
    Brenner, W
    Gläser, R
    Mönig, H
    Henze, E
    Christophers, E
    ONCOLOGY, 1999, 56 (04) : 338 - 344
  • [29] Diagnostic performance of early increase in S100B or LDH as outcome predictor for non-responsiveness to anti-PD-1 monotherapy in advanced melanoma
    Rozeman, Elisa A.
    Versluis, Judith M.
    Moritz, Ruben
    Wilgenhof, Sofie
    van Thienen, Johannes V.
    Haanen, John B. A. G.
    van de Heuvel, Michel M.
    Blank, Christian U.
    van Rossum, Huub H.
    CLINICA CHIMICA ACTA, 2022, 533 : 71 - 78
  • [30] Elevated Levels of Serum S100B is Associated with the Presence and Outcome of Haemorrhagic Shock
    Zhao, Pengcheng
    Gao, Sujie
    Lin, Baisong
    CLINICAL LABORATORY, 2012, 58 (9-10) : 1051 - 1055
12345